Richard Kassberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Richard kassberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Richard Kassberg Today - Breaking & Trending Today

Seven Eight Capital LP Purchases 26,831 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)

Seven Eight Capital LP increased its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 140.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 45,906 shares of the biopharmaceutical company’s stock after purchasing an additional 26,831 shares during the […] ....

United States , Hudson Bay , Thomas Richard Kassberg , Stifel Nicolaus , Royal Bank , Norges Bank , Jpmorgan Chase Co , Ultragenyx Pharmaceutical Inc , Hermes Inc , Exchange Commission , Sands Capital Management , Seven Eight Capital , Ultragenyx Pharmaceutical , Free Report , Eight Capital , Capital Management , Hudson Bay Capital Management , Bay Capital Management , Richard Kassberg , Pharmaceutical Stock Down , Get Free Report , Pharmaceutical Inc , North America , Latin America , Visit Holdingschannel , Ultragenyx Pharmaceutical Daily ,

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares Purchased by Seven Eight Capital LP

Seven Eight Capital LP increased its holdings in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 140.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 45,906 shares of the biopharmaceutical company’s stock after acquiring an additional 26,831 shares during the quarter. Seven […] ....

United States , Thomas Richard Kassberg , Stifel Nicolaus , Securities Exchange Commission , Associates Corp , Covestor Ltd , Exchange Commission , International Assets Investment Management , Canaccord Genuity Group , Ultragenyx Pharmaceutical Inc , Ultragenyx Pharmaceutical Company Profile , Jpmorgan Chase Co , Allspring Global Investments Holdings , Seven Eight Capital , Ultragenyx Pharmaceutical , Free Report , Eight Capital , Assets Investment Management , Global Investments Holdings , Richard Kassberg , Get Free Report , Pharmaceutical Inc , North America , Latin America , Visit Holdingschannel , Ultragenyx Pharmaceutical Daily ,

Ultragenyx Pharmaceutical (NASDAQ:RARE) PT Raised to $115.00

Ultragenyx Pharmaceutical (NASDAQ:RARE) PT Raised to $115.00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Stifel Nicolaus , Thomas Richard Kassberg , Matthewk Fust , Jpmorgan Chase Co , Associates Corp , Covestor Ltd , Cantor Fitzgerald , Canaccord Genuity Group , Securities Exchange Commission , Ultragenyx Pharmaceutical Inc , Headlands Technologies , Ultragenyx Pharmaceutical , Get Free Report , Richard Kassberg , Exchange Commission , Director Matthew , Pharmaceutical Inc , North America , Latin America , Ultragenyx Pharmaceutical Daily ,

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Raised to $111.00 at Canaccord Genuity Group

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Raised to $111.00 at Canaccord Genuity Group
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Robertw Baird , Dekabank Deutsche Girozentrale , Matthewk Fust , Thomas Richard Kassberg , Franklin Resources Inc , Canaccord Genuity Group , Cantor Fitzgerald , Securities Exchange Commission , Royal Bank , Ultragenyx Pharmaceutical Company Profile , Jpmorgan Chase Co , York State Common Retirement Fund , Charles Schwab Investment Management Inc , Ultragenyx Pharmaceutical Inc , Ultragenyx Pharmaceutical , Get Free Report , Genuity Group , Richard Kassberg , Exchange Commission , Director Matthew , Schwab Investment Management , Bank Deutsche Girozentrale , Pharmaceutical Inc , North America ,

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Cut to $76.00

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Cut to $76.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Thomas Richard Kassberg , Matthewk Fust , Stifel Nicolaus , Robertw Baird , Canaccord Genuity Group , Jump Financial , Swiss National Bank , Principal Financial Group Inc , Barclays Plc , Securities Exchange Commission , Ultragenyx Pharmaceutical Inc , Ultragenyx Pharmaceutical , Get Free Report , Director Matthew , Exchange Commission , Richard Kassberg , Financial Group , State Retirement System , National Bank , Pharmaceutical Inc , North America , Latin America , Ultragenyx Pharmaceutical Daily ,